Aurobindo Pharma Ltd
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 5 name spellings.
0
Ending by 2030
Mar 2035
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jul 2, 2027The maintenance fee for Pharmaceutical composition comprising Canagliflozin, process of preparation and use thereof (US 11,857,559) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 2 fees due Oct 28 to 30, 2027 · next Oct 28
- 1 fee due Nov 7, 2027The maintenance fee for Naloxegol oxalate and solid dispersion thereof (US 11,974,996) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,096,945 | Pharmaceutical compositions of linagliptin and process for preparation thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,632,043 | Premix formulation for parenteral use and packaging thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,836,693 | Process for the preparation of docosanol In force · From the USPTO record | In force | From the USPTO record | |
| US 11,974,996 | Naloxegol oxalate and solid dispersion thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,857,559 | Pharmaceutical composition comprising Canagliflozin, process of preparation and use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,273,156 | Stable cariprazine formulations for oral use In force · From the USPTO record | In force | From the USPTO record | |
| US 11,648,242 | Pharmaceutical Composition Comprising Pimavanserin, Process of Preparation and Use Thereof In force · High confidence | In force | High confidence | |
| US 11,969,413 | Pharmaceutical compositions of deutetrabenazine and process for preparation thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 12,221,440 | Process for the preparation of trametinib acetic acid solvate In force · From the USPTO record | In force | From the USPTO record | |
| US 12,285,411 | Pharmaceutical composition comprising eluxadoline, process of preparation and use thereof In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 10: 45 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 15 no status recorded
Showing 1 to 10 of 17, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/643,177 | Pharmaceutical Compositions of Rimegepant | Apr 23, 2024 | Pending |
| 18/204,237 | May 31, 2023 | No status recorded | |
| 18/105,795 | Extended Release Compositions of Pseudoephedrine or Its Pharmaceutically Acceptable Salt Thereof | Feb 3, 2023 | Pending |
| 17/875,117 | Jul 27, 2022 | No status recorded | |
| 16/870,840 | May 8, 2020 | No status recorded | |
| 16/982,548 | Mar 13, 2019 | No status recorded | |
| 16/955,566 | Dec 18, 2018 | No status recorded | |
| 16/767,102 | Nov 21, 2018 | No status recorded | |
| 16/646,081 | Sep 10, 2018 | No status recorded | |
| 16/311,584 | Jun 21, 2017 | No status recorded |
10 of 17 applications shown.
Pro members see all 17 published applications.